ADVANCED PATHO MIDTERM EXAM: NR 507- ADVANCED PATHO, 2025/2026 WITH CORRECT/ACCURATE ANSWERS

ADVANCED PATHO MIDTERM
EXAM: NR 507- ADVANCED PATHO,
2025/2026 WITH
CORRECT/ACCURATE ANSWERS


Phsyiologic manifestation of anemia - CORRECT ANSWERS-
Severe fatigue, pallor, weakness, dyspnea, dizziness

Increased RBC distribution on labs



NYHA Stage 1 - CORRECT ANSWERS- Mild, no limitations of
physical activity

Ordinary activity does not cause symptoms



NYHA Stage 2 - CORRECT ANSWERS- Mild, slight limitation of
physical activity

Comfortable at rest

Ordinary physical activity results in fatigue, palpitations, dyspnea,
anginal pain



NYHA Stage 3 - CORRECT ANSWERS- Moderate, marked decrease
in physical activity

Marked limitation of physical activity

Comfortable at rest

,Less than ordinary activity causes fatigue, palpitations, dyspnea,
or anginal pain



NYHA Stage 4 - CORRECT ANSWERS- severe disability, unable to
tolerate normal ADLs



Intermittent Stage Asthma - CORRECT ANSWERS- Day sx: <2
days/week

Night sx: <2 days/month

Activity level: normal

Severe exacerbation: 0-1/year

FEV1: >80%

FEV1/FEV: normal



Mild Persistent Asthma Stage - CORRECT ANSWERS- Day sx: 2-6
days/week

Night sx: 3-4 day/month

Activity level: Minor limitation

Severe exacerbation: 2/year

FEV1: >80%

FEV1/FEV: Normal



Moderate persistent asthma stage - CORRECT ANSWERS- Day sx:
daily

, Night sx: >1 night/week

Activity level: some limitation

Severe exacerbation: 2/year

FEV1: 60-80%

FEV1/FEV: Decrease by 5% of normal



Severe persistent - CORRECT ANSWERS- Day sx: throughout day

Night sx: nightly

Activity level: Severe limitation

Severe exacerbation: 2/year

FEV1: <60%

FEV1/FEV: Decrease by 5% of normal



COPD Stage 1- Mild - CORRECT ANSWERS- FEV1/FVC ratio <70%

FEV1 >80-100%



COPD Stage 2- Moderate - CORRECT ANSWERS- FEV1/FVC ratio
<70%

FEV1 50-80%



COPD Stage 3- Severe - CORRECT ANSWERS- FEV1/FVC ratio
<70%

FEV1 30-50%